Zankel Todd 4
4 · Raptor Pharmaceutical Corp · Filed Aug 31, 2012
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-08-29$5.01/sh−10,136$50,781→ 659,214 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]This transaction was executed in multiple trades at prices ranging from $5.00 to $5.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.